BKCI

BNY Mellon Concentrated International ETF

$54.98
$0.03 (+0.05%)
Delayed ≥20 min · Aug 13, 2026

Key Statistics

Net Assets (AUM)
$184.00M
Expense Ratio
See prospectus
Previous Close
$54.96
Day Range
- – -
52-Week Range
$47.83 – $55.31
Volume
4.56K
Avg Vol (50D)
-
Beta
0.85

Historical Performance

1M
+3.36%
3M
+4.12%
6M
+5.26%
YTD
+6.62%
1Y
+9.80%
3Y
+21.27%
5Y

Total return including reinvested distributions, from adjusted closing prices.

Price History

Price history is being compiled for this fund.

Top Holdings

ASML ASML Holding NV 5.75%
1299 AIA Group Ltd 5.64%
TSM TSMC 5.63%
AMS Amadeus IT Group SA 4.54%
ROG Roche Holding AG 4.42%
CPG Compass Group PLC 4.20%
TTE TotalEnergies SE 4.13%
ATD Alimentation Couche-Tard Inc 4.11%
7741 Hoya Corp 3.82%
MRK Merck KGaA 3.76%
AI Air Liquide SA 3.68%
OR L'Oreal SA 3.64%
SGSN SGS SA 3.60%
SAP SAP SE 3.53%
KNEBV Kone Oyj 3.49%
CLAR CapitaLand Ascendas REIT 3.41%
MC LVMH Moet Hennessy Louis Vuitt 3.35%
COLOB Coloplast A/S 3.30%
4063 Shin-Etsu Chemical Co Ltd 3.01%
SIKA Sika AG 2.94%
EXPN Experian PLC 2.78%
UMG Universal Music Group NV 2.66%
6861 Keyence Corp 2.66%
CSL CSL Ltd 2.55%
ALC Alcon AG 2.45%

Top 25 holdings as of Jan 30, 2026 · source: SEC N-PORT. Full holdings & prospectus →

About BKCI

To pursue its goal, thefund normally invests primarily in equity securities of foreign companies located in developed markets,excluding the United States. The fund considers "developed markets" to be countries included in theMorgan Stanley Capital International (MSCI) Europe, Australasia andFar East (EAFE®) Index and Canada. "Foreigncompanies" are companies: (i) that are organized under the laws of a foreign country; (ii) whose principaltrading market is in a foreign country; or (iii) that have a majority of their assets, or that derivea majority of their revenue or profits from businesses, investments or sales, outside the United States. The fund ordinarily invests in at least three countries and is not geographically limited in its investmentselection. The fund invests principally in common stocks, including common stocks listed on foreignexchanges.The fund may invest in equity securities ofcompanies of any market capitalization. In addition, the fund may, from time to time,invest a significant portion (more than 20%) of its total assets in equity securities of companies incertain sectors or located in particular regions or countries. As ofDecember 31, 2025, the fund invests a significant portion of its assets in equity securities of companiesin the healthcare sector. In addition, as of December 31, 2025, the fund has significant exposure toequity securities of companies located in Western Europe, particularly France, and Japan. Although the fund's investments will be focused among developed markets, excluding the United States,the fund may invest up to 20% of its assets in emerging markets. Certain of the fund's investments maybe denominated in foreign currencies. It is expected that the currency exposure of the fund's portfoliowill be unhedged to the U.S. dollar.Thefund's sub-adviser, Walter Scott & Partners Limited (Walter Scott), an affiliate of the Adviser,seeks investment opportunities in companies with fundamental strengths that indicate the potential forsustainable long-term growth, thereby benefitting from the power of compounding. Walter Scott focuseson individual equity security selection, building the fund's portfolio from the bottom up through extensivefundamental research. The investment process begins with the screeningof reported company financials. Companies that meet certain broad absolute and trend criteria are candidatesfor more detailed analysis. As part of that analysis, Walter Scott considers all material opportunitiesand risks with respect to a company, financial and non-financial, and regularly engages with companymanagement teams. Walter Scott first restates the company's income statement, flow of funds, and balancesheet to a cash basis, to understand the cash generating strengths of the company and thereby the company'sability to achieve self-financed growth so far as possible. Walter Scott then conducts a detailed investigationof the company's products, cost and pricing, competition and industry position and outlook. In assessingthe valuation of an individual equity security Walter Scott uses various measures, including price-to-earningsratio versus growth rate, price-to-cash ratio, price-to-book ratio and dividend yield. Walter Scottinvests the fund's assets in reasonably valued equity securities of companiesexhibiting market leadership and long-term growth prospects, underpinned by strong management and soundoperating practices. The fund typically invests in 25 to 30 companies. Geographic,sector and industry allocations, as well as allocations to equity securities of companies with varyingmarket capitalizations, are the result of, not part of, the investment process, because Walter Scott'ssole focus is on the analysis of and investment in individual companies. Thefund typically sells an equity security when it no longer possesses the characteristics that caused WalterScott to purchase the security for the fund's portfolio. An equity security may be a sell candidatewhen its valuation reaches or exceeds its calculated fair value, or there are deteriorating fundamentals. Walter Scott may reduce the weighting of an equity security held by the fund if it becomes overweightedas determined by Walter Scott. The fund is non-diversified.

Data for BKCI is aggregated from third-party providers (Tiingo, Nasdaq, Finnhub) and SEC filings, may be delayed at least 20 minutes, and may be incomplete or contain errors. Nothing here is investment advice. Verify with the official prospectus before investing.